Baclofen and cyclobenzaprine are not interchangeable, so calling one “stronger” than the other misses how they actually work. They belong to the same broad category of skeletal muscle relaxants, but they treat different conditions through completely different mechanisms. Baclofen is primarily used for spasticity caused by neurological conditions like multiple sclerosis or spinal cord injuries, while cyclobenzaprine is designed for short-term relief of acute musculoskeletal pain like back spasms or neck strains.
Why “Stronger” Is the Wrong Comparison
Muscle relaxants fall into two distinct groups: antispastic agents and antispasmodic agents. Baclofen is an antispastic drug, meaning it targets the rigid, involuntary muscle tightness that comes from damage to the brain or spinal cord. Cyclobenzaprine is an antispasmodic, meaning it reduces the painful muscle spasms that come from injuries to muscles, tendons, or ligaments. Comparing their strength is like comparing an antibiotic to an antifungal: they’re built for different problems.
No head-to-head clinical trials have directly compared the two drugs against each other. A systematic review from the Agency for Healthcare Research and Quality found insufficient evidence to determine the relative efficacy of most skeletal muscle relaxants against one another. What the research does show is that each drug performs well within its own lane. Baclofen has fair evidence of effectiveness for spasticity, particularly in multiple sclerosis patients. Cyclobenzaprine has been evaluated in more clinical trials than any other muscle relaxant for musculoskeletal conditions and has consistently been found effective for acute back and neck pain.
Notably, baclofen has very limited evidence supporting its use for ordinary musculoskeletal pain. Clinical guidelines from the American Academy of Family Physicians have specifically recommended against prescribing antispastic agents like baclofen for musculoskeletal conditions due to sparse supporting evidence.
How They Work in the Body
Baclofen acts directly on nerve cells in the spinal cord. It activates a specific type of receptor (called GABA-B) that quiets nerve signaling in two ways: it reduces the release of excitatory chemical signals between neurons, and it directly dampens the electrical activity of motor neurons by opening potassium channels. This dual action, both before and after the nerve junction, makes it particularly effective at reducing the constant muscle tightness characteristic of spasticity.
Cyclobenzaprine works higher up in the nervous system, primarily in the brainstem. Its structure is closely related to older antidepressants, and it reduces tonic somatic motor activity by affecting both the gamma and alpha motor systems. In simpler terms, it turns down the volume on the signals your brain sends to keep muscles contracted, which is why it helps with the painful clenching that follows a strain or sprain. It does not act directly on the muscle itself.
Different Timelines and Durations
Baclofen reaches its peak concentration in the blood about three to four hours after you take it. Cyclobenzaprine’s half-life ranges widely, from 8 to 36 hours depending on the individual, which means the drug can linger in your system and its sedating effects may carry well into the next day for some people.
The intended duration of use is also very different. The FDA label for cyclobenzaprine (sold as Flexeril) states it should be used only for short periods, up to two or three weeks, because evidence of effectiveness beyond that point doesn’t exist and acute muscle spasms typically resolve on their own. Baclofen, on the other hand, is often prescribed for months or years because the neurological conditions it treats are chronic.
Side Effects and Sedation
Both drugs cause significant drowsiness. Cyclobenzaprine’s chemical similarity to tricyclic antidepressants means it also commonly causes dry mouth, dizziness, and blurred vision. Its sedating effect is one reason some people perceive it as “strong,” though sedation is a side effect, not a measure of muscle-relaxing power.
Baclofen’s side effects include drowsiness, dizziness, weakness, and confusion, particularly at higher doses. One critical difference is what happens if you stop suddenly. Abrupt baclofen withdrawal can be dangerous, potentially causing altered mental status, fever, worsening spasticity, seizures, and autonomic instability. In severe cases involving intrathecal baclofen (delivered directly into the spinal fluid via a pump), untreated withdrawal can progress to organ failure and death within one to three days. Baclofen should always be tapered gradually under medical supervision. Cyclobenzaprine does not carry the same withdrawal risk.
Which One Is Right for Which Condition
Current clinical guidelines recommend skeletal muscle relaxants as an option for acute or subacute low back pain when non-drug treatments like heat, massage, or spinal manipulation aren’t enough. In that context, cyclobenzaprine is the more studied and more commonly prescribed choice. For acute musculoskeletal injuries that aren’t low back pain, guidelines favor topical anti-inflammatory drugs as first-line treatment, with oral anti-inflammatories or acetaminophen as alternatives.
Baclofen fills a different role entirely. It’s a go-to option for managing spasticity in conditions like multiple sclerosis, spinal cord injury, and cerebral palsy. For patients with severe spasticity that doesn’t respond well to oral baclofen, an intrathecal pump can deliver the drug directly to the spinal fluid at much lower doses. This route bypasses the blood-brain barrier, which oral baclofen crosses poorly, and reduces systemic side effects like sedation.
If you’ve been prescribed one of these medications and are wondering whether the other would work better, the answer almost certainly depends on what’s causing your muscle problems. A person with a pulled back muscle and a person with multiple sclerosis-related leg stiffness have fundamentally different issues, and the drug that works for one is unlikely to help the other.